VETHERAPY
0840.911.410 · rovalta.com · 09/11/2026
VETHERAPY
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBOVETHERAPY is a Private limited company incorporated in 2011. Its main activity is: Veterinary activities. Its registered office is in Anthisnes.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0840.911.410
- Incorporation
- 09/11/2011
- Legal form
- Private limited company
- Registered office
- Chaussée de Liège 19b
4160 Anthisnes · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2025
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 162,9 k € | -18.7% | 200,3 k € | +67.0% | 119,9 k € | -6.5% | 128,3 k € | +99.7% | 64,3 k € |
| EBITDA | 160,3 k € | -18.9% | 197,7 k € | +68.6% | 117,2 k € | -6.7% | 125,6 k € | +97.4% | 63,6 k € |
| Operating result | 150,7 k € | -21.6% | 192,3 k € | +64.1% | 117,2 k € | -9.2% | 129,1 k € | +111% | 61,2 k € |
| Net result | 143,3 k € | -23.0% | 186,1 k € | +65.2% | 112,7 k € | -9.8% | 124,9 k € | +121% | 56,5 k € |
| Balance sheet | |||||||||
| Equity | 60,1 k € | +11.8% | 53,7 k € | -52.5% | 113,2 k € | +6.3% | 106,6 k € | +7.0% | 99,6 k € |
| Total assets | 616,4 k € | +9.1% | 565,2 k € | +18.4% | 477,3 k € | +24.2% | 384,3 k € | +10.1% | 349,2 k € |
| Cash | 323,4 k € | +20.7% | 267,9 k € | +3.7% | 258,4 k € | +79.0% | 144,4 k € | -6.2% | 154 k € |
| Debts | 553,8 k € | +8.9% | 508,7 k € | +40.0% | 363,3 k € | +31.1% | 277,1 k € | +12.1% | 247,3 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/06/20252 active · 2 ended
Active mandates
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Bruno RENETTE | Director08/11/2011 → 2020 accountsManager08/11/2011 → 2019 accounts | |
Olivier LIMBOURG | Director08/11/2011 → 2020 accountsManager08/11/2011 → 2019 accounts |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 02/02/2026 | 14/01/2025 | 22/01/2024 | 30/01/2023 | 31/01/2022 | 05/02/2021 |
| General meeting | 19/12/2025 | 20/12/2024 | 15/12/2023 | 16/12/2022 | 17/12/2021 | 18/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 19/12/2025 | 02/02/2026 | French | |
| Micro model | 30/06/2024 | 20/12/2024 | 14/01/2025 | French | |
| Micro model | 30/06/2023 | 15/12/2023 | 22/01/2024 | French | |
| Micro model | 30/06/2022 | 16/12/2022 | 30/01/2023 | French | |
| Micro model | 30/06/2021 | 17/12/2021 | 31/01/2022 | French | |
| Micro model | 30/06/2020 | 18/12/2020 | 05/02/2021 | French | |
| Micro model | 30/06/2019 | 20/12/2019 | 03/02/2020 | French | |
| Micro model | 30/06/2018 | 21/12/2018 | 28/02/2019 | French | |
| Micro model | 30/06/2017 | 15/12/2017 | 01/02/2018 | French | |
| Abridged model | 30/06/2016 | 16/12/2016 | 23/02/2017 | French | |
| Abridged model | 30/06/2015 | 30/10/2015 | 14/01/2016 | French | |
| Abridged model | 30/06/2014 | 19/12/2014 | 16/01/2015 | French | |
| Abridged model | 30/06/2013 | 31/10/2013 | 23/01/2014 | French | |
| Abridged model | 30/06/2012 | 21/12/2012 | 12/02/2013 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20252 active · 2 ended
Active mandates
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Bruno RENETTE | Director08/11/2011 → 2020 accountsManager08/11/2011 → 2019 accounts | |
Olivier LIMBOURG | Director08/11/2011 → 2020 accountsManager08/11/2011 → 2019 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates10/11/2025STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DENOMINATION - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Mandates07/08/2018DEMISSIONS, NOMINATIONS
- Other22/11/2011RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Chaussée de Liège 19b, 4160 AnthisnesCurrent | accounts 2025 | Accounts 2025 · 2026-00027943 |
| Rue Brihî Tiyou 22, 4590 Ouffet | accounts 2022 → 2024 | Accounts 2024 · 2025-00006606 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| VETHERAPYCurrent | accounts 2025 | Accounts 2025 · 2026-00027943 |
| RENETTE LIMBOURG | accounts 2022 → 2024 | Accounts 2024 · 2025-00006606 |
Events
- 2025Annual accounts 2025143,3 k €↓
- 2025Name changeVETHERAPY
- 2024Annual accounts 2024186,1 k €↑
- 2023Annual accounts 2023112,7 k €↓
- 2022Annual accounts 2022124,9 k €↑
- 2021Annual accounts 202156,5 k €↑
- 2020Annual accounts 202023,4 k €↑
- 2019Annual accounts 20194,5 k €↓
- 2018Annual accounts 201866,7 k €↓
- 2017Annual accounts 201799,7 k €↓
- 2016Annual accounts 2016114 k €↓
- 2015Annual accounts 2015122,8 k €↑
- 2014Annual accounts 2014111,4 k €↑
- 2013Annual accounts 201391,4 k €↓
- 2012Annual accounts 2012108,3 k €
- 09/11/2011IncorporationPrivate limited company